Revu Corporation (KOSDAQ:443250)
South Korea · Delayed Price · Currency is KRW 7,970.00
+310.00 (4.05%)
At close: Apr 30, 2026
Revu Corporation Revenue
In the year 2025, Revu Corporation had annual revenue of 56.46B KRW with 18.05% growth. Revu Corporation had revenue of 16.24B in the quarter ending December 31, 2025, with 5.73% growth.
Revenue
56.46B
Revenue Growth
+18.05%
P/S Ratio
1.56
Revenue / Employee
n/a
Employees
n/a
Market Cap
88.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 56.46B | 8.63B | 18.05% |
| Dec 31, 2024 | 47.82B | 8.08B | 20.32% |
| Dec 31, 2023 | 39.75B | -521.35M | -1.29% |
| Dec 31, 2022 | 40.27B | 17.28B | 75.19% |
| Dec 31, 2021 | 22.99B | 5.68B | 32.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SGC E&C | 1.34T |
| A-Tech Solution | 305.49B |
| Openbase | 233.13B |
| Sinsin Pharmaceutical | 113.78B |
| Tplex | 93.85B |
| Comunication Weaver | 62.60B |
| Samik Pharmaceutical Company LTD. | 60.02B |
| KSIGN | 48.39B |